chr17:39723405:G>A Detail (hg38) (ERBB2)

Information

Genome

Assembly Position
hg19 chr17:37,879,658-37,879,658 View the variant detail on this assembly version.
hg38 chr17:39,723,405-39,723,405

HGVS

Type Transcript Protein
RefSeq NM_004448.3:c.2033G>A NP_004439.2:p.Arg678Gln
NM_001289937.1:c.2033G>A NP_001276866.1:p.Arg678Gln
NM_001005862.2:c.1943G>A NP_001005862.1:p.Arg648Gln
Summary

MGeND

Clinical significance Likely pathogenic
Variant entry 6
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

ClinVar

Clinical Significance Likely pathogenic
Review star
Show details
Links
Type Database ID Link
Gene MIM 164870 OMIM
HGNC 3430 HGNC
Ensembl ENSG00000141736 Ensembl
NCBI NCBI
Gene Cards Gene Cards
OncoKB OncoKB
Type Database ID Link
Variant TogoVar
COSMIC COSM5055424 COSMIC
MONDO
Disease area statistics
MGeND
Clinical significance Last evaluated Condition Origin Submission ID Submitter Institute Citation Comment Image
Likely pathogenic colorectal neoplasms, hereditary nonpolyposis somatic MGS000043
(TMGS000096)
Kohei Miyazono Tokyo University
Likely pathogenic salivary gland neoplasms somatic MGS000044
(TMGS000097)
Kohei Miyazono Tokyo University
ClinVar
Clinical significance Last evaluated Review status Condition Origin Links
Likely pathogenic 2016-05-31 no assertion criteria provided Malignant neoplasm of body of uterus somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided somatic Detail
not provided 2016-03-10 no assertion provided Breast neoplasm somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided prostate adenocarcinoma somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided Neoplasm of the large intestine somatic Detail
Likely pathogenic 2016-05-31 no assertion criteria provided gastric adenocarcinoma somatic Detail
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
breast cancer Lapatinib,Neratinib D Predictive Supports Sensitivity/Response Somatic 5 23220880 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
MCF10A cells transduced with ERBB2 harboring an R678Q mutation were sensitive to lapatinib and the i... CIViC Evidence Detail
NM_004448.4(ERBB2):c.2033G>A (p.Arg678Gln) AND Malignant neoplasm of body of uterus ClinVar Detail
NM_004448.4(ERBB2):c.2033G>A (p.Arg678Gln) AND Transitional cell carcinoma of the bladder ClinVar Detail
NM_004448.4(ERBB2):c.2033G>A (p.Arg678Gln) AND Breast neoplasm ClinVar Detail
NM_004448.4(ERBB2):c.2033G>A (p.Arg678Gln) AND Prostate adenocarcinoma ClinVar Detail
NM_004448.4(ERBB2):c.2033G>A (p.Arg678Gln) AND Neoplasm of the large intestine ClinVar Detail
NM_004448.4(ERBB2):c.2033G>A (p.Arg678Gln) AND Gastric adenocarcinoma ClinVar Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
dbSNP
rs1057519862 dbSNP
Genome
hg38
Position
chr17:39,723,405-39,723,405
Variant Type
snv
Reference Allele
G
Alternative Allele
A
Variant (CIViC) (CIViC Variant)
R678Q
Transcript 1 (CIViC Variant)
ENST00000269571.5
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/42
Summary (CIViC Variant)
ERBB2 R678Q was shown to have NO functional effect in tissue culture assay (Bose et al 2013). This conclusion was confirmed by a second, independent lab.
Genome browser